Supramolecular assemblies in functional siRNA delivery: where do we stand?

HM Aliabadi, B Landry, C Sun, T Tang, H Uludağ - Biomaterials, 2012 - Elsevier
The discovery of RNA interference (RNAi) has excited the scientific field due to its potential
for wide range of therapeutic applications. The pharmacological mediator of RNAi, short …

Polyethylenimine as a promising vector for targeted siRNA delivery

S Nimesh - Current clinical pharmacology, 2012 - ingentaconnect.com
Recent discovery of RNA interference (RNAi) technology for gene therapy has triggered
explosive research efforts towards development of small interfering RNA (siRNA) as …

[HTML][HTML] NEDD9, a novel target of miR-145, increases the invasiveness of glioblastoma

MC Speranza, V Frattini, F Pisati, D Kapetis, P Porrati… - Oncotarget, 2012 - ncbi.nlm.nih.gov
Abstract miR-145 is an important repressor of pluripotency in embryonic stem cells and a
tumor suppressor in different cancers. Here, we found that miR-145 is strongly down …

Well-defined cholesterol polymers with pH-controlled membrane switching activity

S Sevimli, F Inci, HM Zareie, V Bulmus - Biomacromolecules, 2012 - ACS Publications
Cholesterol has been used as an effective component of therapeutic delivery systems
because of its ability to cross cellular membranes. Considering this, well-defined copolymers …

Local Delivery of Chitosan/VEGF siRNA Nanoplexes Reduces Angiogenesis and Growth of Breast Cancer In Vivo

E Şalva, L Kabasakal, F Eren, N Özkan… - Nucleic acid …, 2012 - liebertpub.com
Vascular endothelial growth factor (VEGF) is the important angiogenic factor associated with
tumor growth and metastasis in a wide variety of solid tumors. The aim of this study is to …

Cell-penetrating peptide mimicking polymer-based combined delivery of paclitaxel and siRNA for enhanced tumor growth suppression

YL Jang, UJ Yun, MS Lee, MG Kim, S Son… - International journal of …, 2012 - Elsevier
Cancer chemotherapy is often limited, since more than one molecule is usually involved with
the cancer pathogenesis. A combination of therapeutic drugs would be a promising …

Effective down-regulation of breast cancer resistance protein (BCRP) by siRNA delivery using lipid-substituted aliphatic polymers

HM Aliabadi, B Landry, P Mahdipoor, CYM Hsu… - European journal of …, 2012 - Elsevier
Breast Cancer Resistance Protein (BCRP, ABCG2) is an efflux protein whose aberrant
activity has been linked to multidrug resistance in cancer. Although siRNA delivery to down …

[图书][B] Tissue engineering: principles and practices

JP Fisher, AG Mikos, JD Bronzino, DR Peterson - 2012 - books.google.com
With contributions from experts and pioneers, this book begins with coverage of the
fundamentals, details the supporting technology, and then elucidates their applications in …

Amphiphilic peptides with arginine and valine residues as siRNA carriers

DW Ryu, HA Kim, JH Ryu, DY Lee… - Journal of Cellular …, 2012 - Wiley Online Library
An efficient and safe delivery carrier is required for the therapeutic application of siRNA. In
this research, amphiphilic peptides with arginine and valine residues were evaluated as …

Extraordinarily enhanced gene transfection and cellular uptake by aromatic hydrophobicization to PEI25K

H Jia, X Luo, H Cheng, J Yang, C Li, CW Liu… - Journal of Materials …, 2012 - pubs.rsc.org
Different from commonly used alkylation strategies, PEI25K was modified with rigid, highly
hydrophobic aromatic moieties to develop superior gene vectors with multiple functions …